0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alogliptin Benzoate Tablet Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18O14435
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Alogliptin Benzoate Tablet Market Research Report 2023
BUY CHAPTERS

Global Alogliptin Benzoate Tablet Market Research Report 2025

Code: QYRE-Auto-18O14435
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Alogliptin Benzoate Tablet Market

The global market for Alogliptin Benzoate Tablet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Alogliptin Benzoate Tablet, this product is suitable for the treatment of type 2 diabetes mellitus. 1) Monotherapy This product is used as an adjunct therapy for diet control and exercise to improve blood glucose control in patients with type 2 diabetes mellitus. 2) Combined with metformin hydrochloride When metformin hydrochloride alone cannot effectively control blood glucose, this product can be used in combination with metformin hydrochloride to improve blood glucose control in patients with type 2 diabetes on the basis of diet and exercise. 3) Important Limitations of use This product is not intended for use in patients with type 1 diabetes or diabetic ketoacidosis as its effectiveness has not been determined.
North American market for Alogliptin Benzoate Tablet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Alogliptin Benzoate Tablet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Alogliptin Benzoate Tablet include Takeda Pharmaceutical, Perrigo, Navana Pharmaceuticals, China National Medicines Guorui Pharmaceutical, Reyoung Pharmaceutical, Yichang HEC ChangJiang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Yabao Pharmaceutical, Zhejiang Huabett Pharmaceutical, Sunshine Lake Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alogliptin Benzoate Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alogliptin Benzoate Tablet.
The Alogliptin Benzoate Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alogliptin Benzoate Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alogliptin Benzoate Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alogliptin Benzoate Tablet Market Report

Report Metric Details
Report Name Alogliptin Benzoate Tablet Market
Segment by Type
  • 6.25mg/Tablet
  • 12.5mg/Tablet
  • 25mg/Tablet
Segment by Application
  • Hospital
  • Clinic
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceutical, Perrigo, Navana Pharmaceuticals, China National Medicines Guorui Pharmaceutical, Reyoung Pharmaceutical, Yichang HEC ChangJiang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Yabao Pharmaceutical, Zhejiang Huabett Pharmaceutical, Sunshine Lake Pharma, Jiangsu Deyuan Pharmaceutical, Qianjin Xiangjiang Pharmageuical, CSPC Ouyi Pharmaceutical, Shenzhen Haibin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alogliptin Benzoate Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alogliptin Benzoate Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Alogliptin Benzoate Tablet Market report?

Ans: The main players in the Alogliptin Benzoate Tablet Market are Takeda Pharmaceutical, Perrigo, Navana Pharmaceuticals, China National Medicines Guorui Pharmaceutical, Reyoung Pharmaceutical, Yichang HEC ChangJiang Pharmaceutical, Chongqing Kerui Nanhai Pharmaceutical, Yabao Pharmaceutical, Zhejiang Huabett Pharmaceutical, Sunshine Lake Pharma, Jiangsu Deyuan Pharmaceutical, Qianjin Xiangjiang Pharmageuical, CSPC Ouyi Pharmaceutical, Shenzhen Haibin Pharmaceutical

What are the Application segmentation covered in the Alogliptin Benzoate Tablet Market report?

Ans: The Applications covered in the Alogliptin Benzoate Tablet Market report are Hospital, Clinic, Pharmacy

What are the Type segmentation covered in the Alogliptin Benzoate Tablet Market report?

Ans: The Types covered in the Alogliptin Benzoate Tablet Market report are 6.25mg/Tablet, 12.5mg/Tablet, 25mg/Tablet

Recommended Reports

Antidiabetics Market

Gliptins Products

Diabetes API Market

1 Alogliptin Benzoate Tablet Market Overview
1.1 Product Definition
1.2 Alogliptin Benzoate Tablet by Type
1.2.1 Global Alogliptin Benzoate Tablet Market Value Comparison by Type (2024 VS 2031)
1.2.2 6.25mg/Tablet
1.2.3 12.5mg/Tablet
1.2.4 25mg/Tablet
1.3 Alogliptin Benzoate Tablet by Application
1.3.1 Global Alogliptin Benzoate Tablet Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Alogliptin Benzoate Tablet Market Size Estimates and Forecasts
1.4.1 Global Alogliptin Benzoate Tablet Revenue 2020-2031
1.4.2 Global Alogliptin Benzoate Tablet Sales 2020-2031
1.4.3 Global Alogliptin Benzoate Tablet Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Alogliptin Benzoate Tablet Market Competition by Manufacturers
2.1 Global Alogliptin Benzoate Tablet Sales Market Share by Manufacturers (2020-2025)
2.2 Global Alogliptin Benzoate Tablet Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Alogliptin Benzoate Tablet Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Alogliptin Benzoate Tablet, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alogliptin Benzoate Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alogliptin Benzoate Tablet, Product Type & Application
2.7 Global Key Manufacturers of Alogliptin Benzoate Tablet, Date of Enter into This Industry
2.8 Global Alogliptin Benzoate Tablet Market Competitive Situation and Trends
2.8.1 Global Alogliptin Benzoate Tablet Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alogliptin Benzoate Tablet Players Market Share by Revenue
2.8.3 Global Alogliptin Benzoate Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alogliptin Benzoate Tablet Market Scenario by Region
3.1 Global Alogliptin Benzoate Tablet Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Alogliptin Benzoate Tablet Sales by Region: 2020-2031
3.2.1 Global Alogliptin Benzoate Tablet Sales by Region: 2020-2025
3.2.2 Global Alogliptin Benzoate Tablet Sales by Region: 2026-2031
3.3 Global Alogliptin Benzoate Tablet Revenue by Region: 2020-2031
3.3.1 Global Alogliptin Benzoate Tablet Revenue by Region: 2020-2025
3.3.2 Global Alogliptin Benzoate Tablet Revenue by Region: 2026-2031
3.4 North America Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.4.1 North America Alogliptin Benzoate Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Alogliptin Benzoate Tablet Sales by Country (2020-2031)
3.4.3 North America Alogliptin Benzoate Tablet Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.5.1 Europe Alogliptin Benzoate Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Alogliptin Benzoate Tablet Sales by Country (2020-2031)
3.5.3 Europe Alogliptin Benzoate Tablet Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alogliptin Benzoate Tablet Market Facts & Figures by Region
3.6.1 Asia Pacific Alogliptin Benzoate Tablet Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Alogliptin Benzoate Tablet Sales by Region (2020-2031)
3.6.3 Asia Pacific Alogliptin Benzoate Tablet Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.7.1 Latin America Alogliptin Benzoate Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Alogliptin Benzoate Tablet Sales by Country (2020-2031)
3.7.3 Latin America Alogliptin Benzoate Tablet Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alogliptin Benzoate Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Alogliptin Benzoate Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Alogliptin Benzoate Tablet Sales by Country (2020-2031)
3.8.3 Middle East and Africa Alogliptin Benzoate Tablet Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alogliptin Benzoate Tablet Sales by Type (2020-2031)
4.1.1 Global Alogliptin Benzoate Tablet Sales by Type (2020-2025)
4.1.2 Global Alogliptin Benzoate Tablet Sales by Type (2026-2031)
4.1.3 Global Alogliptin Benzoate Tablet Sales Market Share by Type (2020-2031)
4.2 Global Alogliptin Benzoate Tablet Revenue by Type (2020-2031)
4.2.1 Global Alogliptin Benzoate Tablet Revenue by Type (2020-2025)
4.2.2 Global Alogliptin Benzoate Tablet Revenue by Type (2026-2031)
4.2.3 Global Alogliptin Benzoate Tablet Revenue Market Share by Type (2020-2031)
4.3 Global Alogliptin Benzoate Tablet Price by Type (2020-2031)
5 Segment by Application
5.1 Global Alogliptin Benzoate Tablet Sales by Application (2020-2031)
5.1.1 Global Alogliptin Benzoate Tablet Sales by Application (2020-2025)
5.1.2 Global Alogliptin Benzoate Tablet Sales by Application (2026-2031)
5.1.3 Global Alogliptin Benzoate Tablet Sales Market Share by Application (2020-2031)
5.2 Global Alogliptin Benzoate Tablet Revenue by Application (2020-2031)
5.2.1 Global Alogliptin Benzoate Tablet Revenue by Application (2020-2025)
5.2.2 Global Alogliptin Benzoate Tablet Revenue by Application (2026-2031)
5.2.3 Global Alogliptin Benzoate Tablet Revenue Market Share by Application (2020-2031)
5.3 Global Alogliptin Benzoate Tablet Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Company Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Perrigo
6.2.1 Perrigo Company Information
6.2.2 Perrigo Description and Business Overview
6.2.3 Perrigo Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Perrigo Alogliptin Benzoate Tablet Product Portfolio
6.2.5 Perrigo Recent Developments/Updates
6.3 Navana Pharmaceuticals
6.3.1 Navana Pharmaceuticals Company Information
6.3.2 Navana Pharmaceuticals Description and Business Overview
6.3.3 Navana Pharmaceuticals Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Navana Pharmaceuticals Alogliptin Benzoate Tablet Product Portfolio
6.3.5 Navana Pharmaceuticals Recent Developments/Updates
6.4 China National Medicines Guorui Pharmaceutical
6.4.1 China National Medicines Guorui Pharmaceutical Company Information
6.4.2 China National Medicines Guorui Pharmaceutical Description and Business Overview
6.4.3 China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.4.4 China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.4.5 China National Medicines Guorui Pharmaceutical Recent Developments/Updates
6.5 Reyoung Pharmaceutical
6.5.1 Reyoung Pharmaceutical Company Information
6.5.2 Reyoung Pharmaceutical Description and Business Overview
6.5.3 Reyoung Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Reyoung Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.5.5 Reyoung Pharmaceutical Recent Developments/Updates
6.6 Yichang HEC ChangJiang Pharmaceutical
6.6.1 Yichang HEC ChangJiang Pharmaceutical Company Information
6.6.2 Yichang HEC ChangJiang Pharmaceutical Description and Business Overview
6.6.3 Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.6.5 Yichang HEC ChangJiang Pharmaceutical Recent Developments/Updates
6.7 Chongqing Kerui Nanhai Pharmaceutical
6.7.1 Chongqing Kerui Nanhai Pharmaceutical Company Information
6.7.2 Chongqing Kerui Nanhai Pharmaceutical Description and Business Overview
6.7.3 Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.7.5 Chongqing Kerui Nanhai Pharmaceutical Recent Developments/Updates
6.8 Yabao Pharmaceutical
6.8.1 Yabao Pharmaceutical Company Information
6.8.2 Yabao Pharmaceutical Description and Business Overview
6.8.3 Yabao Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Yabao Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.8.5 Yabao Pharmaceutical Recent Developments/Updates
6.9 Zhejiang Huabett Pharmaceutical
6.9.1 Zhejiang Huabett Pharmaceutical Company Information
6.9.2 Zhejiang Huabett Pharmaceutical Description and Business Overview
6.9.3 Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.9.5 Zhejiang Huabett Pharmaceutical Recent Developments/Updates
6.10 Sunshine Lake Pharma
6.10.1 Sunshine Lake Pharma Company Information
6.10.2 Sunshine Lake Pharma Description and Business Overview
6.10.3 Sunshine Lake Pharma Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sunshine Lake Pharma Alogliptin Benzoate Tablet Product Portfolio
6.10.5 Sunshine Lake Pharma Recent Developments/Updates
6.11 Jiangsu Deyuan Pharmaceutical
6.11.1 Jiangsu Deyuan Pharmaceutical Company Information
6.11.2 Jiangsu Deyuan Pharmaceutical Description and Business Overview
6.11.3 Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.11.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
6.12 Qianjin Xiangjiang Pharmageuical
6.12.1 Qianjin Xiangjiang Pharmageuical Company Information
6.12.2 Qianjin Xiangjiang Pharmageuical Description and Business Overview
6.12.3 Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Product Portfolio
6.12.5 Qianjin Xiangjiang Pharmageuical Recent Developments/Updates
6.13 CSPC Ouyi Pharmaceutical
6.13.1 CSPC Ouyi Pharmaceutical Company Information
6.13.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.13.3 CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.13.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.14 Shenzhen Haibin Pharmaceutical
6.14.1 Shenzhen Haibin Pharmaceutical Company Information
6.14.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.14.3 Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Product Portfolio
6.14.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alogliptin Benzoate Tablet Industry Chain Analysis
7.2 Alogliptin Benzoate Tablet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alogliptin Benzoate Tablet Production Mode & Process Analysis
7.4 Alogliptin Benzoate Tablet Sales and Marketing
7.4.1 Alogliptin Benzoate Tablet Sales Channels
7.4.2 Alogliptin Benzoate Tablet Distributors
7.5 Alogliptin Benzoate Tablet Customer Analysis
8 Alogliptin Benzoate Tablet Market Dynamics
8.1 Alogliptin Benzoate Tablet Industry Trends
8.2 Alogliptin Benzoate Tablet Market Drivers
8.3 Alogliptin Benzoate Tablet Market Challenges
8.4 Alogliptin Benzoate Tablet Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Alogliptin Benzoate Tablet Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Alogliptin Benzoate Tablet Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Alogliptin Benzoate Tablet Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Alogliptin Benzoate Tablet Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Alogliptin Benzoate Tablet Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Alogliptin Benzoate Tablet Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Alogliptin Benzoate Tablet Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Alogliptin Benzoate Tablet, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Alogliptin Benzoate Tablet, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Alogliptin Benzoate Tablet, Product Type & Application
 Table 12. Global Key Manufacturers of Alogliptin Benzoate Tablet, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alogliptin Benzoate Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alogliptin Benzoate Tablet as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alogliptin Benzoate Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Alogliptin Benzoate Tablet Sales by Region (2020-2025) & (K Units)
 Table 18. Global Alogliptin Benzoate Tablet Sales Market Share by Region (2020-2025)
 Table 19. Global Alogliptin Benzoate Tablet Sales by Region (2026-2031) & (K Units)
 Table 20. Global Alogliptin Benzoate Tablet Sales Market Share by Region (2026-2031)
 Table 21. Global Alogliptin Benzoate Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Alogliptin Benzoate Tablet Revenue Market Share by Region (2020-2025)
 Table 23. Global Alogliptin Benzoate Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Alogliptin Benzoate Tablet Revenue Market Share by Region (2026-2031)
 Table 25. North America Alogliptin Benzoate Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Alogliptin Benzoate Tablet Sales by Country (2020-2025) & (K Units)
 Table 27. North America Alogliptin Benzoate Tablet Sales by Country (2026-2031) & (K Units)
 Table 28. North America Alogliptin Benzoate Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Alogliptin Benzoate Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Alogliptin Benzoate Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Alogliptin Benzoate Tablet Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Alogliptin Benzoate Tablet Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Alogliptin Benzoate Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Alogliptin Benzoate Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Alogliptin Benzoate Tablet Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Alogliptin Benzoate Tablet Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Alogliptin Benzoate Tablet Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Alogliptin Benzoate Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Alogliptin Benzoate Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Alogliptin Benzoate Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Alogliptin Benzoate Tablet Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Alogliptin Benzoate Tablet Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Alogliptin Benzoate Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alogliptin Benzoate Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Alogliptin Benzoate Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Alogliptin Benzoate Tablet Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Alogliptin Benzoate Tablet Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Alogliptin Benzoate Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Alogliptin Benzoate Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Alogliptin Benzoate Tablet Sales (K Units) by Type (2020-2025)
 Table 51. Global Alogliptin Benzoate Tablet Sales (K Units) by Type (2026-2031)
 Table 52. Global Alogliptin Benzoate Tablet Sales Market Share by Type (2020-2025)
 Table 53. Global Alogliptin Benzoate Tablet Sales Market Share by Type (2026-2031)
 Table 54. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Alogliptin Benzoate Tablet Revenue Market Share by Type (2020-2025)
 Table 57. Global Alogliptin Benzoate Tablet Revenue Market Share by Type (2026-2031)
 Table 58. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Alogliptin Benzoate Tablet Sales (K Units) by Application (2020-2025)
 Table 61. Global Alogliptin Benzoate Tablet Sales (K Units) by Application (2026-2031)
 Table 62. Global Alogliptin Benzoate Tablet Sales Market Share by Application (2020-2025)
 Table 63. Global Alogliptin Benzoate Tablet Sales Market Share by Application (2026-2031)
 Table 64. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Alogliptin Benzoate Tablet Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Alogliptin Benzoate Tablet Revenue Market Share by Application (2020-2025)
 Table 67. Global Alogliptin Benzoate Tablet Revenue Market Share by Application (2026-2031)
 Table 68. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Application (2026-2031)
 Table 70. Takeda Pharmaceutical Company Information
 Table 71. Takeda Pharmaceutical Description and Business Overview
 Table 72. Takeda Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Takeda Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 74. Takeda Pharmaceutical Recent Developments/Updates
 Table 75. Perrigo Company Information
 Table 76. Perrigo Description and Business Overview
 Table 77. Perrigo Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Perrigo Alogliptin Benzoate Tablet Product
 Table 79. Perrigo Recent Developments/Updates
 Table 80. Navana Pharmaceuticals Company Information
 Table 81. Navana Pharmaceuticals Description and Business Overview
 Table 82. Navana Pharmaceuticals Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Navana Pharmaceuticals Alogliptin Benzoate Tablet Product
 Table 84. Navana Pharmaceuticals Recent Developments/Updates
 Table 85. China National Medicines Guorui Pharmaceutical Company Information
 Table 86. China National Medicines Guorui Pharmaceutical Description and Business Overview
 Table 87. China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. China National Medicines Guorui Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 89. China National Medicines Guorui Pharmaceutical Recent Developments/Updates
 Table 90. Reyoung Pharmaceutical Company Information
 Table 91. Reyoung Pharmaceutical Description and Business Overview
 Table 92. Reyoung Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Reyoung Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 94. Reyoung Pharmaceutical Recent Developments/Updates
 Table 95. Yichang HEC ChangJiang Pharmaceutical Company Information
 Table 96. Yichang HEC ChangJiang Pharmaceutical Description and Business Overview
 Table 97. Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Yichang HEC ChangJiang Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 99. Yichang HEC ChangJiang Pharmaceutical Recent Developments/Updates
 Table 100. Chongqing Kerui Nanhai Pharmaceutical Company Information
 Table 101. Chongqing Kerui Nanhai Pharmaceutical Description and Business Overview
 Table 102. Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Chongqing Kerui Nanhai Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 104. Chongqing Kerui Nanhai Pharmaceutical Recent Developments/Updates
 Table 105. Yabao Pharmaceutical Company Information
 Table 106. Yabao Pharmaceutical Description and Business Overview
 Table 107. Yabao Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Yabao Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 109. Yabao Pharmaceutical Recent Developments/Updates
 Table 110. Zhejiang Huabett Pharmaceutical Company Information
 Table 111. Zhejiang Huabett Pharmaceutical Description and Business Overview
 Table 112. Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Zhejiang Huabett Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 114. Zhejiang Huabett Pharmaceutical Recent Developments/Updates
 Table 115. Sunshine Lake Pharma Company Information
 Table 116. Sunshine Lake Pharma Description and Business Overview
 Table 117. Sunshine Lake Pharma Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sunshine Lake Pharma Alogliptin Benzoate Tablet Product
 Table 119. Sunshine Lake Pharma Recent Developments/Updates
 Table 120. Jiangsu Deyuan Pharmaceutical Company Information
 Table 121. Jiangsu Deyuan Pharmaceutical Description and Business Overview
 Table 122. Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Jiangsu Deyuan Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 124. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
 Table 125. Qianjin Xiangjiang Pharmageuical Company Information
 Table 126. Qianjin Xiangjiang Pharmageuical Description and Business Overview
 Table 127. Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Qianjin Xiangjiang Pharmageuical Alogliptin Benzoate Tablet Product
 Table 129. Qianjin Xiangjiang Pharmageuical Recent Developments/Updates
 Table 130. CSPC Ouyi Pharmaceutical Company Information
 Table 131. CSPC Ouyi Pharmaceutical Description and Business Overview
 Table 132. CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. CSPC Ouyi Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 134. CSPC Ouyi Pharmaceutical Recent Developments/Updates
 Table 135. Shenzhen Haibin Pharmaceutical Company Information
 Table 136. Shenzhen Haibin Pharmaceutical Description and Business Overview
 Table 137. Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Shenzhen Haibin Pharmaceutical Alogliptin Benzoate Tablet Product
 Table 139. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Alogliptin Benzoate Tablet Distributors List
 Table 143. Alogliptin Benzoate Tablet Customers List
 Table 144. Alogliptin Benzoate Tablet Market Trends
 Table 145. Alogliptin Benzoate Tablet Market Drivers
 Table 146. Alogliptin Benzoate Tablet Market Challenges
 Table 147. Alogliptin Benzoate Tablet Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alogliptin Benzoate Tablet
 Figure 2. Global Alogliptin Benzoate Tablet Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alogliptin Benzoate Tablet Market Share by Type: 2024 & 2031
 Figure 4. 6.25mg/Tablet Product Picture
 Figure 5. 12.5mg/Tablet Product Picture
 Figure 6. 25mg/Tablet Product Picture
 Figure 7. Global Alogliptin Benzoate Tablet Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Alogliptin Benzoate Tablet Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Pharmacy
 Figure 12. Global Alogliptin Benzoate Tablet Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Alogliptin Benzoate Tablet Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Alogliptin Benzoate Tablet Sales (2020-2031) & (K Units)
 Figure 15. Global Alogliptin Benzoate Tablet Average Price (US$/Unit) & (2020-2031)
 Figure 16. Alogliptin Benzoate Tablet Report Years Considered
 Figure 17. Alogliptin Benzoate Tablet Sales Share by Manufacturers in 2024
 Figure 18. Global Alogliptin Benzoate Tablet Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Alogliptin Benzoate Tablet Players: Market Share by Revenue in Alogliptin Benzoate Tablet in 2024
 Figure 20. Alogliptin Benzoate Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Alogliptin Benzoate Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Alogliptin Benzoate Tablet Sales Market Share by Country (2020-2031)
 Figure 23. North America Alogliptin Benzoate Tablet Revenue Market Share by Country (2020-2031)
 Figure 24. United States Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Alogliptin Benzoate Tablet Sales Market Share by Country (2020-2031)
 Figure 27. Europe Alogliptin Benzoate Tablet Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Alogliptin Benzoate Tablet Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Alogliptin Benzoate Tablet Revenue Market Share by Region (2020-2031)
 Figure 35. China Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Alogliptin Benzoate Tablet Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Alogliptin Benzoate Tablet Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Alogliptin Benzoate Tablet Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Alogliptin Benzoate Tablet Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Alogliptin Benzoate Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Alogliptin Benzoate Tablet by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Alogliptin Benzoate Tablet by Type (2020-2031)
 Figure 54. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Alogliptin Benzoate Tablet by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Alogliptin Benzoate Tablet by Application (2020-2031)
 Figure 57. Global Alogliptin Benzoate Tablet Price (US$/Unit) by Application (2020-2031)
 Figure 58. Alogliptin Benzoate Tablet Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS